Advanced Filters
noise
Found 64,783 clinical trials
D Dunya N Alfaraj, MD

Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line

Background: Peripheral Intravenous catheter (PIVC) is a frequently used device for intravascular access. It is usually indicated to administer intravenous fluid and medications. However, the investigators could possibly utilize this line for blood sampling even after using it as a fluid port.

18 years of age All Phase 4
J Jasdeep Kaur, PhD

Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population

The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardiovascular health. The investigators will further investigate the affect of Beetroot juice on the vascular function of all participants.

18 - 65 years of age All Phase N/A

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

This is a phase I, open label study employing diphencyprone (DPCP) to characterize gene expression changes of various immune cell and tumor markers in cutaneous metastases treated with topical DPCP twice weekly for 12 weeks in combination with PD-1 or PD-L1 immune checkpoint inhibition (ICI), compared to pre-treatment cutaneous metastases …

18 years of age All Phase 1
A Abdallah A Eldisouky

L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis

This study aims at evaluating the possible efficacy and safety of L-carnitine in rheumatoid arthritis via targeting Jak/STAT pathway and TGF-β1

18 - 70 years of age All Phase 3
H Huasheng Yang, M.D, PHD

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.

years of age All Phase 3

Effect and Safety MABs Administration m.3243A>G Mutation Carriers

The first primary objective is to assess the effect of three intra-arterial administrations of autologous mesoangioblasts (MABs) with respect to improving muscle strength and reduce fatigue of the treated biceps brachii (BB) compared to the untreated BB. The second primary objective is safety of three intra-arterial administrations of autologous MABs, …

18 - 64 years of age All Phase 2

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is an autoimmune disease mainly mediated by autoreactive B cells and the presence of pathogenic anti-platelet auto-antibodies that enhance platelet destruction and impair platelet production. There are approximately 4,000 newly diagnosed ITP cases each year in France. For patients with a platelet count of less than …

18 years of age All Phase 3

A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects

This is a randomized, double-blind, placebo-controlled phase I study to evaluate the safety, tolerability and PK profiles of orally administered VG290131 in healthy subjects. The main questions it aims to answer are: The safety and tolerability of VG290131 when administered orally as a single dose and multiple doses in healthy …

18 - 45 years of age All Phase 1
A Azam S. Ahmed, MD

External Ventricular Drain Placement Stealth Study

External ventricular drain (EVD) placement is performed very often in neurosurgical practices. EVD's are most commonly placed at the bedside using external anatomical landmarks to guide the catheter into the frontal horn of the ipsilateral lateral ventricle. EVDs are often placed due to acute neurological compromise and require timely insertion. …

18 - 88 years of age All Phase N/A

Topical Infliximab for Sterile Corneal Melt

Corneal melt is a complication that could affect very ill eyes and lead to the thinning of the cornea (the clear window covering of the eyes). This thinning can lead to severe consequences such as the leakage of the liquid inside the eye (ocular perforation), or even blindness. Corneal melt …

18 - 80 years of age All Phase 1

Simplify language using AI